Logo-aim
Arch Iran Med. 2022;25(1): 17-25. doi: 10.34172/aim.2022.04

Original Article

Outcomes of COVID-19 in Patients with Inflammatory Bowel Disease: Comparison with Household Members and the Role of IBD Medications

Ali Reza Sima 1 ORCID, Bahar Saberzadeh-Ardestani 1, Homayoon Vahedi 1, Hafez Fakheri 2, Fariborz Mansour-Ghanaei 3, Iradj Maleki 2, Siavosh Nasseri-Moghaddam 1, Hasan Vosoghinia 4, Mohammad Reza Ghadir 5, Ahmad Hormati 5,6, Amir Kasaeian 1,7, Amir Reza Radmard 8, Bardia Khosravi 1, Masoud Malekzadeh 1, Sudabeh Alatab 1, Anahita Sadeghi 1, Nayyereh Aminisani 9, Hossein Poustchi 1, Elnaz Gonoudi 1, Amir Anushiravani 1, Maryam Rayatpisheh 1, Jean-Frederic Colombel 10, Ryan C. Ungaro 10 * ORCID, Reza Malekzadeh 1 * ORCID

Cited by CrossRef: 3

1- Chen L, Hu K, Cheng C, Hu Q, Zhang L, An T, Guo Y, Chen S, Duan G. Risk of adverse outcomes in inflammatory bowel disease patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Colorectal Dis. 2022;37(11):2277 [Crossref]
2- Lin S, Lau L, Chanchlani N, Kennedy N, Ng S. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic. Gut. 2022;71(7):1426 [Crossref]
3- Lee M, Li H, Wasuwanich P, Kim S, Kim J, Jeong G, Park S, Yang J, Kim M, Yon D, Lee S, Koyanagi A, Jacob L, Kim E, Cheon J, Shin J, Smith L. COVID‐19 susceptibility and clinical outcomes in inflammatory bowel disease: An updated systematic review and meta‐analysis. Reviews in Medical Virology. 2023;33(2) [Crossref]

SCImago Journal & Country Rank

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.